Topic:Disease Prevention
Disease prevention in horses encompasses strategies and practices aimed at minimizing the occurrence and spread of infectious and non-infectious diseases within equine populations. These practices include vaccination programs, biosecurity measures, and regular health monitoring. Vaccination helps to stimulate the horse's immune system to protect against specific pathogens, while biosecurity measures, such as quarantine and sanitation, reduce the risk of disease transmission. Regular health monitoring, including physical examinations and diagnostic testing, aids in early detection and management of potential health issues. This page compiles peer-reviewed research studies and scholarly articles that explore various methods and their effectiveness in preventing diseases in horses, as well as the development and implementation of prevention programs in different equine settings.
Practical aspects of equine virus abortion in the United Kingdom. The current knowledge of the clinical signs, epidemiology and pathogenesis of abortion due to the equid herpesvirus (EHV 1) is reviewed. The relationship between the respiratory and abortigenic forms of the disease is discussed as well as the low incidence of virus abortion in the UK compared to some other parts of the world. Some practical aspects of the disease as they affect stud management are considered including methods of diagnosis, prophylaxis and the necessary action to be taken to prevent spread of infection.
The pregnancy protecting effect of progesterone against human chorionic gonadotrophin challenge in mares. 14 pregnant Welsh Mountain Pony mares were treated with progesterone in an effort to prevent pregnancy failure induced by administration of human chorionic gonadotropin (GCG). 13 of the 14 mares were treated with progesterone by injection or implant before the 38th day of pregnancy. HCG was given in 3 doses on alternate days at a dose rate of 2000 imc/day. The remaining mare was treated with HCG toward the end of the experiments to demonstrate the abortifacient property of HCG. 3 mares aborted and 1 of these was anovulatory thereafter. Further research is needed to determine the effective prog...
Transmission of equine infectious anemia virus by Tabanus fuscicostatus. The mechanical transmission of equine infectious anemia (EIA) virus by Tabanus fuscicostatus was investigated. In 1 of 7 transmission trials, a single horsefly transmitted EIA virus from an acutely infected pony to a susceptible pony. Groups of horseflies isolated for 3, 10, or 30 minutes before refeeding transmitted EIA virus, whereas those isolated for 4 or 24 hours did not. Data from field studies indicate that the home range or flight distance of horseflies may exceed 4 miles. That information together with our observations suggest that segregation of infected horses (usually defined as at...
Vaccination by the non-parenteral route of virus disease in the veterinary field. After a brief reference to the importance of the non-parenteral route of vaccination of domestic animals in general, the author deals, for each animal species separately, with the most important vaccines utilised by this method of administration. On the basis of bibliographical data, he describes the history of this use, discusses the results of the application in the field and draws the relative conclusions.
Immunization of man and animals against influenza by oral and intranasal routes. Live human and equine influenza virus strains modified by serial passage on allantois-on-shell system (AOS) in the presence of normal horse serum were administered orally or intranasally to volunteers or horses. Mostly mild clinical short-lasting reactions, replication in nasal mucosae, transmission to placebo recipients and significant local or circulating antibody rises were observed following administration to volunteers of strains modified by five or less serial passages on AOS in the presence of normal horse serum (NHS). Milder clinical reactions, no replication, no viral transmission and...
Immunity to Streptococcus equi. Using the long chain test, and in some cases the bactericidal test, to measure antibody, the development of the immune response in horses to Str. equi has been followed. Long chain indices in excess of 5.0, accompanied by strong bactericidal capacity, were recorded in serums after the full 3-dose immunisation course with a commercial vaccine. The full course elicited the most satisfactory antibody titres declined within the 12 month post-vaccination period, thus providing support for the recommendation that yearly booster doses should be administered. The immune response in horses during 2 str...
A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis. As a result of the continuing threat of Venezuelan equine encephalomyelitis (VEE), a study was made to determine if revaccination against VEE (TC-83 vaccine) was feasible and if revaccination could be incorporated into other routine vaccination practices. Of the horses given annual vaccination with bivalent western equine encephalomyelitis (WEE) and eastern equine encephalomyelitis (EEE) vaccine, 57% retained detectable serum-neutralizing (SN) antiboyd titers for VEE 18 months after the initial VEE vaccination was given. Of horses with no record of WEE-EEE vacinnation, 100% retained detectable...
Babesiosis in the newborn foal. A short account is given of babesiosis (equine biliary fever) caused by the tick-borne protozoan Babesia equi and B. caballi, endemic in the Cape Province of South Africa. The clinical picture, diagnosis and treatment are described. In the absence of any prophylactic measures, prognosis is poor; control of the parasites in the tick-infested areas is essential.
[Prevention of tetanus in man and animal following injury]. The effect of heterologous and homologous antitoxin is the same if an equal amount of antitoxin is present in the organism. In man there are no circulating antibodies in the blood after the first injection of the toxoid because there is no natural immunity against the tetanus antigen. After the second injection, man develops the same immunity as animals. Large antitoxin doses protect people for a longer period than small doses. Normally 3,000 I. U. of the heterologous antitoxin protects people for 2 to 3 weeks. In man and sheep 2 ml of the adsorbed vaccine produces an earlier and longer-lastin...